CDK2 and hepatocellular carcinoma: Subsequently, WB analysis of cell cycle-related proteins revealed that the expression of CDK2, CDK4, and Cyclin D1 were all suppressed by Regorafenib intervention in both SK-Hep-1 and HCC-LM3 cells (Fig. 4C).